Skip to content
Peptigraph home

Mazdutide for Metabolism: What the Evidence Shows

What human and animal studies show about Mazdutide for metabolism, how strong that evidence is, and what is still unproven.

Medical review pendingGLP-1 / glucagon dual agonistUpdated
Strongest evidence
Human RCT
Human studies
3
with an outcome for metabolism, in our evidence file (PubMed search, 2 Oct 2026)
Animal studies
None found
with an outcome for metabolism, in our evidence file (PubMed search, 2 Oct 2026)
Studies we summarised
3
with an outcome for metabolism

Evidence for metabolism

Each row is an outcome related to metabolism from a published study, strongest design first. Animal and cell results are labelled and are not human results. User reports are not counted as evidence here.

Mazdutide for metabolism: outcomes in published studies
OutcomeResultStudy typeSource
HbA1c at week 24 (primary)HbA1c changed by -2.15% with 6 mg and -1.57% with 4 mg versus -0.14% with placebo at week 24.Human RCTn = 320Nature 2026, PMID 41407859
HbA1c vs dulaglutideVersus dulaglutide 1.5 mg, HbA1c differed by -0.24% (4 mg) and -0.30% (6 mg) at week 28.Human RCTn = 731Nature 2026, PMID 41407860
HbA1c at week 20 (primary)HbA1c changed by -1.41% to -1.67% with mazdutide versus -1.35% with dulaglutide and 0.03% with placebo at week 20.Human RCTDiabetes care 2024, PMID 37943529

Mazdutide and metabolism are not in our PubMed count ledger yet; the rows above come from our evidence file (PubMed search, 2 Oct 2026). Grades follow our .

How strong is it?

Strongest evidence:Human RCT evidence, 4 of 4Nature 2026, PMID 41407859

A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.

Metabolic syndrome as MedlinePlus puts it

MedlinePlus says having at least three of the listed risk factors is what is called metabolic syndrome.[4]

Metabolic measures in the trials

In type 2 diabetes, weight fell 5.61% with 4 mg and 7.81% with 6 mg of mazdutide against 1.26% with placebo at week 24.[1]

In the 20-week trial, body weight fell dose-dependently by up to 7.1% with mazdutide against 2.7% with dulaglutide.[3]

Versus dulaglutide, body weight differed by -3.78% with 4 mg and -5.76% with 6 mg of mazdutide.[2]

Other peptides people research for metabolism

All peptides for metabolism, compared

Common questions

Does Mazdutide help with metabolism?

The strongest study we summarise for metabolism is human rct evidence, across 3 studies with an outcome for metabolism. A trial result is not an approval; see the legal status.

Is Mazdutide approved for metabolism?

No. Mazdutide is not FDA approved for any use, including metabolism.

What is the best peptide for metabolism?

There is no single answer. Our metabolism overview compares each candidate by evidence grade and legal status rather than by popularity.

Does mazdutide improve metabolic health?

The trials report weight and HbA1c changes; none reports a diagnosis of metabolic syndrome as an outcome.

Calculated from trials cited 3; metabolic syndrome outcomes 0. Formula: metabolic-syndrome outcomes among cited trials = 0 of 3

More on Mazdutide

Sources

  1. 1Mazdutide versus placebo in Chinese adults with type 2 diabetes.Nature · 2026PMID 41407859Accessed 2 Oct 2026
  2. 2Mazdutide versus dulaglutide in Chinese adults with type 2 diabetes.Nature · 2026PMID 41407860Accessed 2 Oct 2026
  3. 3Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.Diabetes care · 2024PMID 37943529Accessed 2 Oct 2026
  4. 4Official web pageOfficial web page · web page

Found an error? Report a correction.